Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Measuring citrate synthase activity as an enzymatic approach to the differentiation of chilled and frozen/thawed meat.

Škorpilová T, Šístková I, Adamcová M, Pohůnek V, Kružík V, Ševčík R.

Meat Sci. 2019 Dec;158:107856. doi: 10.1016/j.meatsci.2019.05.027. Epub 2019 May 30.

PMID:
31430644
2.

In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline.

Pokorna Z, Jirkovsky E, Hlavackova M, Jansova H, Jirkovska A, Lencova-Popelova O, Brazdova P, Kubes J, Sotakova-Kasparova D, Mazurova Y, Adamcova M, Vostatkova L, Holzerova K, Kolar F, Simunek T, Sterba M.

Clin Sci (Lond). 2019 Aug 27;133(16):1827-1844. doi: 10.1042/CS20190139. Print 2019 Aug 30.

PMID:
31409729
3.

Lisinopril reverses behavioural alterations in spontaneously hypertensive rats.

Repova K, Aziriova S, Kovacova D, Trubacova S, Baka T, Kanska R, Barta A, Stanko P, Zorad S, Molcan L, Adamcova M, Paulis L, Simko F.

Gen Physiol Biophys. 2019 May;38(3):265-270. doi: 10.4149/gpb_2019011.

PMID:
31184313
4.

Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs.

Adamcova M, Skarkova V, Seifertova J, Rudolf E.

Int J Mol Sci. 2019 May 29;20(11). pii: E2638. doi: 10.3390/ijms20112638.

5.

Ivabradine does not impair anxiety-like behavior and memory in both healthy and L-NAME-induced hypertensive rats.

Krajcirovicova K, Aziriova S, Baka T, Repova K, Adamcova M, Paulis L, Simko F.

Physiol Res. 2018 Dec 31;67(Supplementum 4):S655-S664.

6.

Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension.

Simko F, Baka T, Poglitsch M, Repova K, Aziriova S, Krajcirovicova K, Zorad S, Adamcova M, Paulis L.

Int J Mol Sci. 2018 Oct 3;19(10). pii: E3017. doi: 10.3390/ijms19103017.

7.

Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.

Duricova D, Dvorakova E, Hradsky O, Mitrova K, Durilova M, Kozeluhova J, Kohout P, Zarubova K, Bronsky J, Hradska N, Bronska E, Adamcova M, Machkova N, Hruba V, Bortlik M, Lukas M, Malickova K, Lukas M.

Inflamm Bowel Dis. 2019 Mar 14;25(4):789-796. doi: 10.1093/ibd/izy294.

PMID:
30239799
8.

Effect of melatonin on the behaviour of rats with continuous light-induced hypertension.

Repova K, Krajcirovicova K, Mullerova M, Aziriova S, Baka T, Zorad S, Slavkovsky P, Hodosy J, Celec P, Adamcova M, Paulis L, Simko F.

Gen Physiol Biophys. 2018 Jul;37(4):469-473. doi: 10.4149/gpb_2017061. Epub 2018 Jun 29.

PMID:
29956672
9.

Multiplex biomarker approach to cardiovascular diseases.

Adamcova M, Šimko F.

Acta Pharmacol Sin. 2018 Jul;39(7):1068-1072. doi: 10.1038/aps.2018.29. Epub 2018 Apr 12. Review.

10.

What prevents cardioprotective drugs from reaching the market?

Simko F, Adamcova M.

Expert Rev Clin Pharmacol. 2018 May;11(5):463-465. doi: 10.1080/17512433.2018.1447924. Epub 2018 Mar 12. No abstract available.

PMID:
29495886
11.

Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension.

Simko F, Baka T, Krajcirovicova K, Repova K, Aziriova S, Zorad S, Poglitsch M, Adamcova M, Reiter RJ, Paulis L.

Molecules. 2018 Jan 29;23(2). pii: E265. doi: 10.3390/molecules23020265.

12.

Relations between markers of cardiac remodelling and left ventricular collagen in an isoproterenol-induced heart damage model.

Adamcova M, Baka T, Dolezelova E, Aziriova S, Krajcirovicova K, Karesova I, Stanko P, Repova K, Simko F.

J Physiol Pharmacol. 2019 Feb;70(1). doi: 10.26402/jpp.2019.1.08. Epub 2019 Apr 20.

13.

Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats.

Dolezelova E, Prasnicka A, Cermanova J, Carazo A, Hyrsova L, Hroch M, Mokry J, Adamcova M, Mrkvicova A, Pavek P, Micuda S.

World J Gastroenterol. 2017 Nov 21;23(43):7678-7692. doi: 10.3748/wjg.v23.i43.7678.

14.

Paediatric Home Parenteral Nutrition in the Czech Republic and Its Development: Multicentre Retrospective Study 1995-2011.

Stýblová J, Kalousová J, Adamcová M, Bajerová K, Bronský J, Fencl F, Karásková E, Keslová P, Melek J, Pozler O, Sebroň V, Šuláková A, Tejnická J, Tláskal P, Tomášek L, Vlková B, Szitányi P; Czech Home Parenteral Nutrition Group of the Society of Clinical Nutrition and Intensive Metabolic Care.

Ann Nutr Metab. 2017;71(1-2):99-106. doi: 10.1159/000479339. Epub 2017 Jul 29.

PMID:
28768249
15.

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.

Simko F, Pechanova O, Repova K, Aziriova S, Krajcirovicova K, Celec P, Tothova L, Vrankova S, Balazova L, Zorad S, Adamcova M.

Int J Mol Sci. 2017 Jul 25;18(8). pii: E1612. doi: 10.3390/ijms18081612.

16.

Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae).

Siatka T, Adamcová M, Opletal L, Cahlíková L, Jun D, Hrabinová M, Kuneš J, Chlebek J.

Molecules. 2017 Jul 14;22(7). pii: E1181. doi: 10.3390/molecules22071181.

17.

Effect of ivabradine, captopril and melatonin on the behaviour of rats in L-nitro-arginine methyl ester-induced hypertension.

Aziriova S, Repova K, Krajcirovicova K, Baka T, Zorad S, Mojto V, Slavkovsky P, Hodosy J, Adamcova M, Paulis L, Simko F.

J Physiol Pharmacol. 2016 Dec;67(6):895-902.

18.

[Von Hippel-Lindau syndrome - two sides of the same coin].

Páleníková P, Adamcová M, Šturdík I, Ftáčniková B, Copáková L, Payer J.

Vnitr Lek. Winter 2016;62(12):1004-1008. Review. Czech.

PMID:
28139130
19.

Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?

Lenčová-Popelová O, Jansová H, Jirkovský E, Bureš J, Jirkovská-Vávrová A, Mazurová Y, Reimerová P, Vostatková L, Adamcová M, Hroch M, Pokorná Z, Kovaříková P, Šimůnek T, Štěrba M.

Toxicology. 2016 Nov 30;372:52-63. doi: 10.1016/j.tox.2016.11.002. Epub 2016 Nov 2.

PMID:
27816693
20.

[DRESS syndrome].

Adamcová M, Šturdík I, Koller T, Payer J.

Vnitr Lek. 2016 Apr;62(4):334-7. Czech.

PMID:
27250614
21.

Cardiac troponins--Translational biomarkers in cardiology: Theory and practice of cardiac troponin high-sensitivity assays.

Adamcova M, Popelova-Lencova O, Jirkovsky E, Simko F, Gersl V, Sterba M.

Biofactors. 2016 Mar-Apr;42(2):133-48. doi: 10.1002/biof.1261. Epub 2016 Feb 15. Review.

PMID:
26876101
22.

Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.

Lenčová-Popelová O, Jirkovský E, Jansová H, Jirkovská-Vávrová A, Vostatková-Tichotová L, Mazurová Y, Adamcová M, Chládek J, Hroch M, Pokorná Z, Geršl V, Šimůnek T, Štěrba M.

J Mol Cell Cardiol. 2016 Feb;91:92-103. doi: 10.1016/j.yjmcc.2015.12.021. Epub 2015 Dec 23.

PMID:
26724189
23.

Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.

Adamcova M, Lencova-Popelova O, Jirkovsky E, Mazurova Y, Palicka V, Simko F, Gersl V, Sterba M.

Int J Cardiol. 2015 Dec 15;201:358-67. doi: 10.1016/j.ijcard.2015.07.103. Epub 2015 Aug 4.

PMID:
26310978
24.

Eye disorders reported with the use of mefloquine (Lariam(®)) chemoprophylaxis--A drug safety database analysis.

Adamcova M, Schaerer MT, Bercaru I, Cockburn I, Rhein HG, Schlagenhauf P.

Travel Med Infect Dis. 2015 Sep-Oct;13(5):400-8. doi: 10.1016/j.tmaid.2015.04.005. Epub 2015 Apr 30.

PMID:
26119539
25.

Effects of captopril, spironolactone, and simvastatin on the cardiovascular system of non-diseased Wistar rats.

Simko F, Pechanova O, Krajcirovicova K, Matuskova J, Pelouch V, Adamcova M, Paulis L.

Int J Cardiol. 2015;190:128-30. doi: 10.1016/j.ijcard.2015.04.092. Epub 2015 Apr 15. No abstract available.

PMID:
25918064
26.

[The most recent aspects of diagnosis and therapy of hyponatraemia].

Šturdík I, Adamcová M, Payer J.

Vnitr Lek. 2015 Mar;61(3):209-18. Review. Czech.

PMID:
25873117
27.

Isoquinoline alkaloids as prolyl oligopeptidase inhibitors.

Cahlíková L, Hulová L, Hrabinová M, Chlebek J, Hošťálková A, Adamcová M, Šafratová M, Jun D, Opletal L, Ločárek M, Macáková K.

Fitoterapia. 2015 Jun;103:192-6. doi: 10.1016/j.fitote.2015.04.004. Epub 2015 Apr 9.

PMID:
25863351
28.

Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.

Toovey S, Nieforth K, Smith P, Schlagenhauf P, Adamcova M, Tatt I, Tomianovic D, Schnetzler G.

Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt B):726-32.

PMID:
25443997
29.

Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin.

Simko F, Pechanova O, Repova Bednarova K, Krajcirovicova K, Celec P, Kamodyova N, Zorad S, Kucharska J, Gvozdjakova A, Adamcova M, Paulis L.

Mediators Inflamm. 2014;2014:703175. doi: 10.1155/2014/703175. Epub 2014 Jul 6.

30.

Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril.

Aziriova S, Repova Bednarova K, Krajcirovicova K, Hrenak J, Rajkovicova R, Arendasova K, Kamodyova N, Celec P, Zorad S, Adamcova M, Paulis L, Simko F.

Pharmacol Biochem Behav. 2014 Sep;124:284-9. doi: 10.1016/j.pbb.2014.06.021. Epub 2014 Jun 28.

PMID:
24983779
31.

Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure.

Simko F, Bednarova KR, Krajcirovicova K, Hrenak J, Celec P, Kamodyova N, Gajdosechova L, Zorad S, Adamcova M.

J Pineal Res. 2014 Sep;57(2):177-84. doi: 10.1111/jpi.12154. Epub 2014 Jul 10.

PMID:
24942291
32.

Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.

Lenčová-Popelová O, Jirkovský E, Mazurová Y, Lenčo J, Adamcová M, Šimůnek T, Geršl V, Štěrba M.

PLoS One. 2014 May 7;9(5):e96055. doi: 10.1371/journal.pone.0096055. eCollection 2014.

33.

Hyponatraemia is an independent predictor of in-hospital mortality.

Sturdik I, Adamcova M, Kollerova J, Koller T, Zelinkova Z, Payer J.

Eur J Intern Med. 2014 Apr;25(4):379-82. doi: 10.1016/j.ejim.2014.02.002. Epub 2014 Feb 26. Erratum in: Eur J Intern Med. 2014 Oct;25(8):784.

PMID:
24582329
34.

Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats.

Hrenák J, Arendášová K, Rajkovičová R, Aziriová S, Repová K, Krajčírovičová K, Celec P, Kamodyová N, Bárta A, Adamcová M, Paulis L, Simko F.

Physiol Res. 2013;62 Suppl 1:S181-9.

35.

Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24 hour light-induced hypertension.

Repová-Bednárová K, Aziriová S, Hrenák J, Krajčírovičová K, Adamcová M, Paulis L, Simko F.

Physiol Res. 2013;62 Suppl 1:S135-41.

36.

Use of anti-malarial drugs and the risk of developing eye disorders.

Schneider C, Adamcova M, Jick SS, Schlagenhauf P, Miller MK, Rhein HG, Meier CR.

Travel Med Infect Dis. 2014 Jan-Feb;12(1):40-7. doi: 10.1016/j.tmaid.2013.07.007. Epub 2013 Aug 28.

PMID:
24035311
37.

Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.

Jirkovský E, Lenčová-Popelová O, Hroch M, Adamcová M, Mazurová Y, Vávrová J, Mičuda S, Šimůnek T, Geršl V, Štěrba M.

Toxicology. 2013 Sep 15;311(3):191-204. doi: 10.1016/j.tox.2013.06.012. Epub 2013 Jul 4.

PMID:
23831762
39.

Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders.

Schneider C, Adamcova M, Jick SS, Schlagenhauf P, Miller MK, Rhein HG, Meier CR.

Travel Med Infect Dis. 2013 Mar-Apr;11(2):71-80. doi: 10.1016/j.tmaid.2013.02.008. Epub 2013 Mar 29.

PMID:
23541791
40.

Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.

Jirkovsky E, Popelová O, Kriváková-Stanková P, Vávrová A, Hroch M, Hasková P, Brcáková-Dolezelová E, Micuda S, Adamcová M, Simůnek T, Cervinková Z, Gersl V, Sterba M.

J Pharmacol Exp Ther. 2012 Nov;343(2):468-78. doi: 10.1124/jpet.112.198358. Epub 2012 Aug 22.

PMID:
22915767
41.

Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy.

Schlagenhauf P, Blumentals WA, Suter P, Regep L, Vital-Durand G, Schaerer MT, Boutros MS, Rhein HG, Adamcova M.

Clin Infect Dis. 2012 Jun;54(11):e124-31. doi: 10.1093/cid/cis215. Epub 2012 Apr 10.

42.

Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data.

Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Bansod S, Rhein HG.

Malar J. 2011 Oct 7;10:292. doi: 10.1186/1475-2875-10-292. Review.

43.

Proteomic insights into chronic anthracycline cardiotoxicity.

Stěrba M, Popelová O, Lenčo J, Fučíková A, Brčáková E, Mazurová Y, Jirkovský E, Simůnek T, Adamcová M, Mičuda S, Stulík J, Geršl V.

J Mol Cell Cardiol. 2011 May;50(5):849-62. doi: 10.1016/j.yjmcc.2011.01.018. Epub 2011 Jan 31.

PMID:
21284945
44.

The position of mefloquine as a 21st century malaria chemoprophylaxis.

Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG.

Malar J. 2010 Dec 9;9:357. doi: 10.1186/1475-2875-9-357. Review.

45.

Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment.

Paulis L, Pechanova O, Zicha J, Liskova S, Celec P, Mullerova M, Kollar J, Behuliak M, Kunes J, Adamcova M, Simko F.

J Hypertens. 2010 Sep;28 Suppl 1:S19-24. doi: 10.1097/01.hjh.0000388490.28213.de.

PMID:
20823712
46.

Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril.

Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Celec P, Palffy R, Bednarova K, Vrankova S, Adamcova M, Paulis L.

J Hypertens. 2010 Sep;28 Suppl 1:S13-8. doi: 10.1097/01.hjh.0000388489.28213.08.

PMID:
20823711
47.

Veterinary and toxicological applications for the detection of cardiac injury using cardiac troponin.

Serra M, Papakonstantinou S, Adamcova M, O'Brien PJ.

Vet J. 2010 Jul;185(1):50-7. doi: 10.1016/j.tvjl.2010.04.013. Epub 2010 Jun 2.

PMID:
20621713
48.

Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.

Adamcová M, Potáčová A, Popelová O, Stěrba M, Mazurová Y, Aupperle H, Geršl V.

Physiol Res. 2010;59(5):831-6. Epub 2010 Apr 20.

49.

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Mullerova M, Bednarova K, Adamcova M, Paulis L.

J Hypertens Suppl. 2009 Aug;27(6):S5-10. doi: 10.1097/01.hjh.0000358830.95439.e8.

PMID:
19633453
50.

Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.

Paulis L, Pechanova O, Zicha J, Krajcirovicova K, Barta A, Pelouch V, Adamcova M, Simko F.

J Hypertens Suppl. 2009 Aug;27(6):S11-6. doi: 10.1097/01.hjh.0000358831.33558.97.

PMID:
19633445

Supplemental Content

Loading ...
Support Center